RNAZ · Transcode Therapeutics, Inc.
$2.18
-0.10 (-4.39%)
At close · Aug 28
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Due to the Company's recurring and expected continuing losses from operations, the Company has concluded there is substantial doubt concerning its ability to continue as a going concern for one year after the issuance of these consolidated financial statements without additional capital becoming available.”View the 10-Q filed Aug 14, 2026
Market Cap
$36.42M
Shares
16.93M
Transcode Therapeutics, Inc. Earnings Call Transcripts
Quarterly earnings calls for Transcode Therapeutics, Inc. (RNAZ), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.